3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
29
Myelodysplastic Syndromes
10
Advanced Solid Tumors
8
Leukemia, Myelomonocytic, Chronic
6
Myeloproliferative Disorders
5
Advanced Solid Tumor
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Ovarian Neoplasms
4
Neoplasms
4
Advanced Solid Tumour
4
Multiple Myeloma
3
Lung Neoplasms
3
Leukemia, Monocytic, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Thrombocythemia, Essential
2
Squamous Cell Carcinoma of Head and Neck
2
Solid Tumor
2
Small Cell Lung Carcinoma
2
Recurrence
2
Prostatic Neoplasms
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Biphenotypic, Acute
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Advanced Malignant Solid Tumor
2
Interventions
Oxaliplatin
16
Cetuximab
13
Leucovorin
12
Fluorouracil
12
Bevacizumab
10
pembrolizumab
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
6
Irinotecan
6
Capecitabine
6
encorafenib
4
Pemetrexed
4
Gemcitabine
4
Cisplatin
4
cemiplimab
3
Folfox protocol
3
Early Intervention, Educational
3
Carboplatin
3
Biopsy
3
trifluridine tipiracil drug combination
2
relatlimab
2
pertuzumab
2
palbociclib
2
fludarabine
2
durvalumab
2
dehydroftorafur
2
aldesleukin
2
adagrasib
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Injections
×
90 days
×
Clear all
No trials found.